Recently,the global trend in nanomedicine for cancer therapy has been toward the design of highly sophisticated,carrier-based,and targeted nanoscale drug delivery system for improving therapeutic efficacy.However,offering sophistication generally increases their complexity and introduces their quality concerns and carrier-related toxicity issues that might be disadvantageous in pharmaceutical development[1].